Objective. To examine 11 candidate genes as susceptibility loci for osteoarthritis (OA). Methods. A total of 481 families have been ascertained in which at least two siblings have had joint replacement surgery of the hip, or knee, or hip and knee for idiopathic OA. Each candidate gene was targeted using one or more intragenic or closely linked microsatellite marker. The linkage data were analysed unstratified and following stratification by sex and by joint replaced (hip or knee).
Idiopathic osteoarthritis (OA) is a debilitating disease environmental factors. However, a Finnish twin study involving degeneration of the articular cartilage of synhas suggested that genetic susceptibility may be greater ovial joints. The histology of OA varies from minor in women than men [4] and this result has been superosion of cartilage to total cartilage loss requiring joint ported by a segregation analysis [5] . These studies have replacement surgery [1] . OA has long been considered tended to concentrate on patients with hand, knee, or an inevitable consequence of ageing. However, it has hand and knee OA. Some studies have attempted to become increasingly apparent that OA does have a quantify the risks of developing OA for specific joints genetic component. Twin studies have estimated that and differences in the heritability values between joint the heritability of radiographic OA of the hand, knee groups have been reported [3, 6, 7] . These results suggest and hip ranges from 36 to 68% [2] , whilst relative risk that there may be genetic heterogeneity of OA between calculations have revealed that first-degree relatives of the sexes and between different joint groups. individuals who have had hip or knee joint replacement A number of candidate genes have been proposed as surgery for OA have up to a 2.3-fold increased risk of potential susceptibility loci for idiopathic OA. These developing end-stage disease [3] . These studies also genes predominantly encode structural proteins of the highlight the fact that environmental factors are importextracellular matrix. Particular emphasis has been placed ant in the aetiology of OA, placing idiopathic OA into on the gene for type II collagen (COL2A1) which is the the common, multifactorial class of genetic diseases. major cartilage collagen. There are two principal reasons It has often been noted in epidemiological studies that for this: (i) COL2A1 encodes the most abundant protein there is a female preponderance for OA. This may be of the cartilage extracellular matrix and (ii) mutaaccounted for by differential effects on the two sexes of tions in COL2A1 have been found in severa osteochondrodysplasias. Osteo-chondrodysplasias are rare monogenic diseases of cartilage and bone which components. The involvement of COL2A1 in the Patients and methods osteo-chondrodysplasia ocular-Stickler syndrome is OA families particularly interesting as this disease involves precocious, early-onset OA [8] . Less severe mutations of the Families with at least two siblings who had undergone COL2A1 gene could account for some cases of one or more replacements of the total hip, or of the idiopathic OA. Indeed, linkage has been established total knee, or both, for primary idiopathic OA were to COL2A1 in a couple of rare families in which recruited. A detailed description of these families has early-onset OA segregates as a Mendelian trait [9] . been published elsewhere [19] . Furthermore, null alleles of COL2A1 have been reported
Candidate genes in some individuals with idiopathic OA [10], whilst two studies have suggested association of polymorphisms in
The candidate genes examined are shown in Table 1 , the vitamin D receptor gene (which is syntenic with which also lists the polymorphic markers used to target COL2A1) with OA [11, 12] . However, other studies each candidate. Where available, intragenic markers were used. Other markers were chosen that were 5 cM have excluded COL2A1 as a high impact susceptibility or less from the candidate gene. For the COL2A1/VDR locus [13] .
locus, the variable number of tandem repeat ( VNTR) Other candidates proposed as potential susceptibility marker located immediately downstream of the loci include genes that encode additional structural COL2A1 gene [28] and two additional markers were proteins of the cartilage extracellular matrix, particularly used to cover chromosome 12q13-q14 (D12S368 and those that, like COL2A1, have been implicated in osteo-D12S87). chondrodysplasias. These include the type XI collagen genes COL11A1 and COL11A2 (non-ocular Stickler
Polymerase chain reaction (PCR), gel electrophoresis disease) [14, 15] , the type IX collagen gene COL9A2
and genotyping (multiple epiphyseal dysplasia) [16 ] and the cartilage Either the forward or the reverse primer in a PCR pair oligomeric matrix protein gene, COMP (multiple epiphywas fluorescently labelled and amplification products seal dysplasia and pseudoachondroplasia) [17] .
were electrophoresed through Applied Biosystems 373 Two loci which do not encode cartilage structural or 377 Automated DNA Sequencers as described proteins but which have been considered as potential by Reed et al. [29] . P-value for stage 1 only then this would support linkage There are a number of candidates which merit analysis at that marker. There was no difference in the ascertainas susceptibility loci for OA and in this paper we ment criteria between the stage 1 and stage 2 familiesdescribe the results of an analysis of 11 such candidate once a reasonably large number of families had been genes. To test for linkage we used an affected sibling collected we began stage 1 of our linkage strategy. pair approach and recruited affected pairs using joint
As well as analysing all the stage 1 families together, replacement surgery for idiopathic OA as our ascertainthese families were also stratified into those containing ment criterion. Our aim was to use families whose affected females-only (132 families), affected males-only idiopathic OA was severe and is therefore more likely (60 families), hips-only (male and/or female) (194 familto have involved a genetic component. We used a twoies), knees-only (male and/or female) (34 families), stage approach. In the first stage all candidate microaffected females-only who had undergone hip replacesatellites were genotyped in 297 of our 481 families. Any ment but not knee replacement (female-hip) (85 families) candidate that demonstrated evidence for linkage at and affected males-only who had undergone hip replacea P-value ∏ 0.05 in the 297 families or in a stratified ment but not knee replacement (male-hip) (44 families). subset of the families (stratified by sex and by hip or We did not stratify by female-knee or male-knee as the knee joint replacement) was then analysed in the number of families was too low (16 and four, respectively) to allow reliable inference of linkage. Again, any remaining 184 families. were combined. We therefore adjusted the stratified LOD scores and P-values to correct for the number of these alleles unambiguously. In consequence this marker strata tested [30] . For stage 1 we deducted log 6 = 0.78 was abandoned. from original LOD scores and multiplied original PTwo of the 19 markers had a P-value ∏0.05: the values by 6, whilst for stage 2, and for stage 1 and 2 HLA/COL11A2 marker D6S273 (P = 0.017) and the combined, we deducted log 3 = 0.48 from original LOD diastrophic dysplasia sulphate transporter gene scores and multiplied original P-values by 3.
(DTDST ) marker CSF1R(CA) n (P = 0.0093). Stratified linkage analysis. Table 2 . Also included COL9A1 marker 509-8B2 for hips-only (P = 0.042) and for female-hips (P = 0.028), HLA/COL11A2 marker are the mean IBD allele sharing and the polymorphism information content (PIC ) values of the markers calcu-D6S265 for hips-only (P = 0.024) and HLA/COL11A2 marker D6S273 for females-only (P = 0.018) and for lated from stage 1. The -myc poly(A) repeat polymorphism is reported to have alleles that differ by 2 bp female-hips (P = 0.014) ( Table 4) . Overall, microsatellite markers for four of our 11 [22] . However, in the current analysis several alleles differed by only 1 bp and it was not possible to assign candidate genes had evidence for linkage at P ∏ 0.05, either in the unstratified data (HLA/COL11A2 and one or more of the following strata: females-only, hipsonly or female-hips. We therefore restricted our strati-DTDST ) or in the stratified data (COL9A1 and fication analysis of COL9A1 and HLA/COL11A2 in HLA/COL11A2). The six markers targeting these four stage 2, and stages 1 and 2 combined, to these three genes were therefore genotyped in the 184 families strata. of stage 2.
In stage 2, the COL9A1 marker 509-8B2 had uncorStage 2 rected P-values ∏ 0.05 for females-only (P = 0.034) and Unstratified linkage analysis. None of the six markers for female-hips (P = 0.024) ( Table 6 ). However, followhad a P-value ∏ 0.05 in the unstratified families of ing correction for the three tests performed, none of the stage 2 ( Table 5) . After combining data for screens 1 four markers targeting COL9A1 and HLA/COL11A2 and 2, only DTDST marker (CA) n had a P-value ∏0.05 had a P-value ∏0.05 in any of the three strata, although (P = 0.022). This compares with a P-value of 0.0093 for 509-8B2 did approach significance in females-only stage 1 only-increasing the number of families studied (P = 0.10) and female-hips (P = 0.072). When stages 1 had reduced the evidence for linkage at this marker. and 2 were combined ( Table 7) 509-8B2 had a corrected Stratified linkage analysis. In the corrected results P-value ∏ 0.05 in females-only (P = 0.01) and femalefrom the stage 1 stratification COL9A1 and hips (P = 0.0016) and approached significance in hipsonly (P = 0.051). 509-12B1 was also significant for HLA/COL11A2 markers were significant at P ∏ 0.05 in female-hips (P = 0.042). The HLA/COL11A2 marker Overall, these comparisons indicate that increasing the number of families studied increases the evidence for D6S273 had a corrected P-value ∏0.05 in females-only (P = 0.01) and female-hips (P = 0.016). D6S265 was linkage at the COL9A1 and HLA/COL11A2 loci in females-only and female-hips. This suggests that our also significant in female-hips (P = 0.025) and approached significance in females-only (P = 0.054).
results for these loci in these two strata are real rather than false positives. . This greater number of females-only would procorrected P-values between stage 1 and stages 1 and 2 combined. For the COL9A1 marker 509-8B2, the vide this strata with greater power to detect linkage and may account for our ability to detect linkage in females-P-value in stages 1 and 2 combined was less than the P-value in stage 1 for females-only (0.01 vs 0.12) and only but not in males-only. However, the difference in the stage 1 P-values for the COL9A1 and for female-hips (0.0016 vs 0.028), and was only slightly increased in hips-only (0.051 vs 0.042). For 509-12B1, HLA/COL11A2 markers between the two strata is striking with no evidence for linkage in males-only the P-value for the combined was also less than the stage 1 P-value for female-hips (0.042 vs 0.084). For (P-values = 0.50 and LOD scores = 0.00 for each marker, Table 3 ). Although the 42 males-only families the HLA/COL11A2 marker D6S265, the P-value for the combined was less than the stage 1 P-value for femalesof stage 2 were not a strata specifically tested in stage 2 (and therefore stages 1 and 2 combined ), these families only (0.054 vs 0.41) and for female-hips (0.025 vs 0.066) but increased for hips-only (0.15 vs 0.024). A similar were genotyped by default since a proportion of them constituted the hips-only families. Again, the COL9A1 pattern was observed for D6S273, with a decreased combined P-value in females-only (0.01 vs 0.018), a and HLA/COL11A2 markers each had a P-value of 0.50 (LOD = 0.00) in the 102 males-only families of slightly increased P-value in female-hips (0.016 vs 0.014) and an increased P-value in hips-only (0.50 vs 0.28). stages 1 and 2 combined. Another factor that could affect power is the informativeness of the families and Of the 11 genes targeted, two demonstrated evidence of suggestive linkage at a P-value of ∏0.05 when the the degree to which IBD status can be determined, which will be influenced by the number of siblings typed 297 families of stage 1 were analysed without stratification: the HLA/COL11A2 locus and DTDST. Analysis who have an 'unknown' clinical status. There was, however, no significant difference in these numbers of these two genes in an additional 184 families demonstrated no evidence of linkage and when the data for between females-only and males-only (data not shown). Furthermore, the PIC values for the COL9A1 and HLA/ stages 1 and 2 were combined only the DTDST gene still supported linkage at P ∏ 0.05. However, the COL11A2 markers in females-only and males-only were not significantly different (data not shown). Of our total P-value for the DTDST (CA) n marker was greater in the combined stages than in stage 1 only, suggesting of 481 families, 185 were affected pairs that contained an affected brother and affected sister and so were not that the positive result in stage 1 was probably a false positive. used in the stratification analysis. Linkage to the COL9A1 and HLA/COL11A2 markers was not signifiWhen we stratified our stage 1 results and corrected for multiple testing, the COL9A1 marker 509-8B2 was cant in these affected pairs [P = 0.14, PIC = 0.72 for 509-8B2, P = 0.50, PIC = 0.76 for 509-12B1, P = 0.50, significant in hips-only and female-hips, the HLA/COL11A2 marker D6S265 was significant in hips-PIC = 0.72 for D6S265, P = 0.40, PIC = 0.75 for D6S273 (P-values are uncorrected)]. Overall, these only and female-hips and the HLA/COL11A2 marker D6S273 was significant in females-only. No markers results suggest that the specific nature of the COL9A1 and HLA/COL11A2 linkages with their restriction to targeting the remaining eight candidate genes were significant in the six strata tested. Despite correction, these females-only is not an artefact of power differences between the strata. Regarding the apparent linkage positive stratification results could still be false. The two-stage nature of our linkage analysis strategy enabled differences between hips-only and knees-only, there were significantly more hips-only families than knees-only us to test this possibility in that we were able to genotype the COL9A1 and HLA/COL11A2 markers in additional families (194 vs 34 in stage 1) and this could account for our inability to detect linkage in the knees-only families. After correction, none of the four markers genotyped in stage 2 were significant in any of the three strata. strata tested. However, this was not unexpected: to have repeated the significant results in an independent data Nodal OA set (which had lower numbers in each of the strata As mentioned in the Introduction, the association that tested ) would have been surprising [31] . Nevertheless, has previously been reported for both the HLA gene 509-8B2 did approach significance in females-only and cluster and the a1-antitrypsin gene is to nodal generalfemale-hips. A more informative analysis was the comized OA [18] . We therefore analysed the D6S265, parison between the P-values obtained in stage 1 with D6S273 and the intragenic a1-antitrypsin markers in those of stages 1 and 2 combined: a reduction in those families from stage 1 which contained at least two P-values when more families were genotyped (i.e. when affected siblings who were concordant for the presence the power of the study was increased ) would support of three or more Heberden's nodes. Of the 297 families the positive results of stage 1. These comparisons in stage 1, 29 were concordant for this phenotype and revealed a reduced P-value in the combined vs stage 1 the P-values obtained for each marker were >0.1 for 509-8B2 in females-only and female-hips (with a very (uncorrected).
moderate increase in P-value for hips-only), a reduced P-value for the second COL9A1 marker 509-12B1 in female-hips, a reduced P-value for the two HLA/ Discussion COL11A2 markers (D6S265 and D6S273) in femalesonly with a reduced P-value for D6S265 in female-hips Linkage analysis has proved to be an essential tool in the genetic dissection of rare monogenic diseases and is and only a very moderate increase in the P-value for D6S273 in this strata. Overall, therefore, now being applied to the identification of loci that predispose to the common, complex disorders. Using increasing the number of families increased the evidence for linkage of the COL9A1 and the HLA/COL11A2 highly polymorphic markers and large numbers of families with small numbers of affected relatives it is possible markers in females-only and female-hips, suggesting that these positive results are probably real. to detect reproducible distortions of allele transmittance that indicate the presence of a nearby susceptibility Why the linkage should be restricted to females-only deserves comment, particularly so for COL9A1 where locus. If the pathology of a disease is reasonably well understood, it is possible to target genes as susceptibility the difference between females-only and males-only is particularly striking. The obvious possibility is that the loci. For OA there are several strong candidates that merit targeting. In this study candidates were chosen on susceptibility at COL9A1 is mediated through a pathway that involves a female-specific hormonal element. the basis that they had previously been implicated in idiopathic OA (or in a rare monogenic disease in which Females are at a greater risk than males of developing OA, and this risk increases after the menopause [1] . OA is one of the phenotypic components) and that intragenic or closely linked polymorphic markers were Indeed, hormone replacement therapy can affect the development and/or progression of OA in females [32] . available to test for linkage.
